Page last updated: 2024-08-24

gemcitabine and ciclopirox

gemcitabine has been researched along with ciclopirox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bouvet, M; Fujimura, K; Kaushal, S; Kelber, JA; Klemke, RL; Lowy, AM; Metildi, C; Strnadel, J; Wright, T1
Gordon, DJ; Goss, KL1

Other Studies

3 other study(ies) available for gemcitabine and ciclopirox

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
    Cancer research, 2014, Nov-15, Volume: 74, Issue:22

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Deoxycytidine; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Humans; Lysine; Mice; Pancreatic Neoplasms; Peptide Initiation Factors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyridones; ras Proteins; RNA-Binding Proteins

2014
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
    Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Ciclopirox; Cloning, Molecular; Deoxycytidine; DNA Damage; Down-Regulation; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mice; Neoplasm Transplantation; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Pyridones; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; RNA-Binding Protein EWS; RNA, Small Interfering; S Phase; Sarcoma, Ewing; Transcriptome

2016